Garvicin KS Multi-Peptide Composition Antibacterial Activity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antimicrobial agents face challenges with antibiotic resistance, particularly in treating multidrug-resistant bacteria, and existing bacteriocins have narrow inhibition spectra, limiting their effectiveness against a broad range of pathogens.
Innovation Solution
A multi-peptide composition comprising at least three peptides, specifically Garvicin KS, which is a broad-spectrum antibacterial agent derived from Lactococcus garvieae, offering potent activity against various gram-positive pathogens, including antibiotic-resistant strains, with a unique combination of peptides that associate to achieve synergistic antibacterial effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat bacterial infections, then bacterial growth is inhibited, but antibiotic resistance develops reducing treatment effectiveness
Solution Approach 1:
The patent changes the chemical structure parameters by designing peptides with specific amino acid sequences (e.g., incorporating tryptophan residues at positions 6 and 11, hydrophobic residues at positions 3, 9, and 17) to create bacteriocins with novel mechanisms of action that bypass antibiotic resistance mechanisms
Solution Approach 2:
The patent creates composite antimicrobial agents by combining multiple peptides (e.g., L1-5, LsbB, and other bacteriocins) into formulations that work synergistically to inhibit bacterial growth through multiple mechanisms, preventing resistance development
2Adaptability or versatility
If single-peptide bacteriocins are used to target bacteria, then specific bacterial strains are inhibited, but the inhibition spectrum remains narrow limiting broad applicability
Solution Approach 1:
The patent merges multiple bacteriocin peptides into combined formulations (e.g., combining L1-5 with LsbB and other peptides) to achieve broad-spectrum antibacterial activity while maintaining high potency against specific pathogens through synergistic effects
Solution Approach 2:
The patent designs bacteriocin compositions with universal applicability by selecting peptides that target conserved bacterial structures (e.g., cell wall synthesis enzymes, membrane components) that are present across diverse bacterial species while maintaining selective toxicity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Garvicin KS demonstrates superior broad-spectrum antibacterial activity, comparable to or exceeding that of nisin, effectively targeting and killing antibiotic-resistant bacteria such as MRSA and VRE, with enhanced potency and stability, making it suitable for use in both medical and food industry applications.
Implementation Method 1
Bacteriocins bind to specific receptors on target membranes to kill cells
Implementation Method 2
a unique combination of peptides that associate to achieve synergistic antibacterial effects
Data Source
AI summary
The present invention provides a multi-peptide composition with antibacterial activity comprising at least 3 peptides with the sequences as set forth in SEQ ID NO:1, 2 or 3 (or related sequences), respectively, in which the SEQ ID NO:1 sequence (or its related sequence) comprises at least two tryptophan residues. In particular the invention provides a new bacteriocin, Garvicin KS. The invention also provides compositions and host cells containing such antibacterial compositions. Uses of the antibacterial composition in treating bacterial infection and products treated with the antibacterial composition are also provided.